2012 Achema Exhibition in Frankfurt, the OMEGA® Economic Dispersionizer was first presented to the public. The sophisticated design and the convincing performance parameters drew considerable interest.
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, announces today that Hybrigenics Services, its fully-owned subsidiary specialised in protein interactions, has renewed a 3-year research services agreement worth USD 2.4 million with an American life sciences company.
STYL’One Evolution , combining the ability to perform compression studies fast and
easy and the capacity of full high-speed rotary press simulation, this R&D press will
leave its competitors far behind.
Performing disintegration tests has mostly remained a time-consuming task where results are recorded manually and unproductive waiting & cleaning times represent a significant portion of daily machine utilization. The new DisiTest 50 disintegration tester from Dr. Schleuniger® Pharmatron incorporates innovative induction heating technology and combines it with the benefits of automation to realize cost savings by significantly streamlining the disintegration testing process.
The SmartTest 50 sets new standards in semi-automatic testing of up to 5 physical parameters (weight, thickness, width, diameter/length, and hardness) of virtually all tablet shapes with one single unit. In full compliance with current Pharmacopeia requirements, the system offers highest precision, flexibility and exceptional user-friendliness.
PPCE, a high-quality Clinical Data Management services company providing CDISC-certified services announced today that it has entered into a strategic partnership agreement with ECLINSO AG, a leading provider of eClinical information technology, consulting and business process outsourcing services.
Pierrel Research is proud to announce that it is selected in the shortlist for the "Best Technological Development in Clinical Trials" of the Scrip Awards 2012.
With the biopharmaceutical industry's drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a range of new devices such as pen and auto injectors have also been introduced to improve administration, safety and accuracy for end-users.
FDA approvals, revenue gain and organic business growth are just a few of the topics that John Fraher, President, Aptalis Pharma, addresses during an on-air interview with Fintan Walton, CEO, PharmaVentures and PharmaTelevision. The interview, conducted during BIO 2012 in Boston, reflects Fraher’s commentary regarding the integration of companies post Axcan Intermediate Holdings’ acquisition of Eurand N.V. in 2011.
Stratophase, a high-end engineering company developing advanced sensor systems, is pleased to announce the launch of Ranger™, its system for the biopharmaceutical industry that provides real-time, in-line bioprocess monitoring and fermentation control, to increase yields of fully functional biologics.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.